{"name":"Doma Biopharmaceutical（Suzhou）Co., Ltd.","slug":"doma-biopharmaceutical-suzhou-co-ltd","ticker":"","exchange":"","domain":"","description":"Doma Biopharmaceutical (Suzhou) Co., Ltd. is a biotechnology company focused on the development of innovative therapies. The company's lead candidate, DM005, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOWEJPWTNpMFdRYlFBaWhWY3B5Vk1fNmRQWmp3VHFvdWlxVVBUTGF5UnE0cTkyZF9DWjBJWDVzTmxjcEZsSDV1MmI4UGN6Vnh6TUZkSUtDQ05qc2V3YW82aDRJUm1tODU5TGJLYXFacU00WlNNZlBjUklNeWlCUGRvSUROdXZwbDFZbzBVSi1hWC13WHJmbnlEME9jV2lEc3puQVhNQm9iaFpQNjg?oc=5","date":"2023-11-10","type":"pipeline","source":"BioWorld News","summary":"DM-005, a bispecific ADC with robust efficacy in preclinical models - BioWorld News","headline":"DM-005, a bispecific ADC with robust efficacy in preclinical models","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}